Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$0.22 - $0.58 $264 - $696
1,200 Added 8.22%
15,800 $4,000
Q3 2023

Nov 07, 2023

BUY
$0.47 - $1.87 $1,410 - $5,610
3,000 Added 25.86%
14,600 $8,000
Q2 2023

Aug 08, 2023

SELL
$1.44 - $2.26 $720 - $1,130
-500 Reduced 4.13%
11,600 $17,000
Q1 2023

May 12, 2023

BUY
$1.1 - $2.86 $13,310 - $34,606
12,100 New
12,100 $20,000

Others Institutions Holding MYMD

About MyMD Pharmaceuticals, Inc.


  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.